Skip to main content
ST PHARM CO., LTD. logo

ST PHARM CO., LTD. — Investor Relations & Filings

Ticker · 237690 ISIN · KR7237690003 KO Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2025-03-07 AGM Information
Country KR South Korea
Listing KO 237690

About ST PHARM CO., LTD.

https://www.stpharm.co.kr/en

ST PHARM CO., LTD. is a global Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs). The company provides technology-driven manufacturing services for gene therapies, with core expertise in oligonucleotides and various forms of RNA (xRNA), including messenger RNA (mRNA). In addition to nucleic acid-based medicines, ST Pharm offers custom manufacturing for small molecule APIs. The company's services operate under cGMP (current Good Manufacturing Practice) standards, providing comprehensive solutions that support the entire drug development lifecycle, from research and development to commercial-scale production for its global pharmaceutical partners.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for ST Pharm Co., Ltd. It details the date, location, agenda items (such as financial statement approval, director appointments, and dividend declarations), and procedures for electronic voting. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming Annual General Meeting (AGM). According to the provided definitions, documents detailing materials and agendas for an AGM are classified as AGM-R.
2025-03-07 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Reference Document) for ST Pharm Co., Ltd. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the agenda (financial statement approval, articles of incorporation changes, director appointments), voting procedures (electronic/written), and proxy solicitation details. This document is a standard regulatory filing required under Korean law to solicit shareholder votes for an AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-07 Korean
주주총회소집결의 (정기주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for the company 'ST Pharm'. It details the meeting date, location, agenda items (such as financial statement approval, dividend declaration, director appointments, and remuneration limits), and provides specific details on board candidates. This document is a standard proxy solicitation/notice of meeting sent to shareholders to inform them of the upcoming vote, which falls under the Proxy Solicitation & Information Statement category.
2025-02-28 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from ST Pharm regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the upcoming shareholder meeting date for approval. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2025-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a change in financial structure (sales or profit/loss) of 30% or more. It provides a summary table of financial results (revenue, operating profit, net income) and explains the reasons for the changes. This is a standard 'Earnings Release' (ER) type of disclosure in the Korean market, providing key financial highlights before the final audited annual report is finalized. FY 2024
2025-02-25 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, purpose (NDR), and the method of presentation. It is a short announcement (under 5,000 characters) notifying stakeholders of an event and the availability of materials, rather than the presentation itself. Therefore, it falls under the category of a Regulatory Filing (RNS) or a general announcement of an event.
2025-02-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.